KalVista Pharmaceuticals (KALV) Insider Trading & Ownership $11.98 +0.26 (+2.22%) (As of 10/15/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends KalVista Pharmaceuticals (NASDAQ:KALV) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.30%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$5.81 MNumber OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$2.76 M Get KALV Insider Trade Alerts Want to know when executives and insiders are buying or selling KalVista Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address KALV Insider Buying and Selling by Quarter Ad Porter & CompanyThe real reason Elon is fully endorsing TrumpElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows, KalVista Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/9/2024Benjamin L PalleikoCEOSell7,352$12.19$89,620.88 8/23/2024Paul K AudhyaInsiderSell2,135$12.40$26,474.00 8/19/2024Benjamin L PalleikoCEOSell14,215$12.01$170,722.15 8/19/2024Christopher YeaInsiderSell7,102$12.01$85,295.02 6/7/2024Benjamin L PalleikoCEOSell7,465$11.53$86,071.45 5/20/2024Benjamin L PalleikoCEOSell21,959$11.76$258,237.84 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/20/2024Edward P FeenerInsiderSell8,088$11.76$95,114.88 2/20/2024Benjamin L PalleikoCFOSell22,802$14.11$321,736.22 2/20/2024Edward P FeenerInsiderSell28,288$14.07$398,012.16 2/20/2024Thomas Andrew CrockettCEOSell24,888$14.11$351,169.68 2/8/2024Venrock Healthcare Capital ParMajor ShareholderBuy29,747$14.70$437,280.90 2/6/2024Venrock Healthcare Capital ParMajor ShareholderBuy4,474$14.74$65,946.76 1/29/2024Venrock Healthcare Capital ParMajor ShareholderBuy80,600$14.22$1,146,132.00 1/26/2024Venrock Healthcare Capital ParMajor ShareholderBuy4,174$12.98$54,178.52 1/24/2024Venrock Healthcare Capital ParMajor ShareholderBuy20,686$12.44$257,333.84 1/22/2024Venrock Healthcare Capital ParMajor ShareholderBuy67,546$12.55$847,702.30 1/18/2024Venrock Healthcare Capital ParMajor ShareholderBuy39,680$12.51$496,396.80 1/16/2024Venrock Healthcare Capital ParMajor ShareholderBuy19,599$12.73$249,495.27 1/11/2024Edward P FeenerInsiderSell22,679$13.03$295,507.37 1/10/2024Venrock Healthcare Capital ParMajor ShareholderBuy47,700$12.67$604,359.00 1/8/2024Edward P FeenerInsiderSell17,221$13.01$224,045.21 1/8/2024Venrock Healthcare Capital ParMajor ShareholderBuy69,184$12.44$860,648.96 1/3/2024Venrock Healthcare Capital ParMajor ShareholderBuy17,605$12.20$214,781.00 12/29/2023Venrock Healthcare Capital ParMajor ShareholderBuy6,013$12.49$75,102.37 12/27/2023Thomas Andrew CrockettCEOSell30,000$12.02$360,600.00 12/27/2023Venrock Healthcare Capital ParMajor ShareholderBuy41,514$11.97$496,922.58 (Data available from 1/1/2013 forward) KALV Insider Trading Activity - Frequently Asked Questions Who is on KalVista Pharmaceuticals's Insider Roster? The list of insiders at KalVista Pharmaceuticals includes Albert Cha, Benjamin L Palleiko, Christopher Yea, Edward P Feener, Paul K Audhya, Thomas Andrew Crockett, and Venrock Healthcare Capital Par. Learn more on insiders at KALV. What percentage of KalVista Pharmaceuticals stock is owned by insiders? 12.30% of KalVista Pharmaceuticals stock is owned by insiders. Learn more on KALV's insider holdings. Which KalVista Pharmaceuticals insiders have been buying company stock? The following insider purchased KALV shares in the last 24 months: Venrock Healthcare Capital Par ($5,806,280.30). How much insider buying is happening at KalVista Pharmaceuticals? Insiders have purchased a total of 448,522 KALV shares in the last 24 months for a total of $5,806,280.30 bought. Which KalVista Pharmaceuticals insiders have been selling company stock? The following insiders have sold KALV shares in the last 24 months: Albert Cha ($189,000.00), Benjamin L Palleiko ($1,149,407.95), Christopher Yea ($117,895.74), Edward P Feener ($1,012,679.62), Paul K Audhya ($138,664.52), and Thomas Andrew Crockett ($989,479.34). How much insider selling is happening at KalVista Pharmaceuticals? Insiders have sold a total of 299,137 KalVista Pharmaceuticals shares in the last 24 months for a total of $3,597,127.17 sold. More Insider Trading Tools from MarketBeat Related Companies: ALIM Insider Selling BCRX Insider Selling MIRM Insider Selling ARVN Insider Selling KNSA Insider Selling NTLA Insider Selling CNTA Insider Selling RCUS Insider Selling NAMS Insider Selling SNDX Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 2 Stocks to Buy and 1 to Sell - Smart Moves for Investors3 Mid-Cap Stocks Under $20 With Insider Buying and Major UpsideInsiders Hold Tight as Helen of Troy Prepares for a Major ReboundInsiders Are Betting Big on These 2 StocksThis Is the Top Large-Cap Stock Insiders Are Buying This page (NASDAQ:KALV) was last updated on 10/16/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredRetire off just one stock ticker?ONE AI Stock is All You Need... There are over 6,000 stocks listed in the market right now. They will NOT m...Behind the Markets | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredAI Detects Profit Surge On MondayThis has given investors the opportunity to beat the market by 1,700% and a 100% win rate to begin the year.Monument Traders Alliance | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KalVista Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share KalVista Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KALV Stock Alerts